Sinotherapeutics Inc. (SHA:688247)
China flag China · Delayed Price · Currency is CNY
11.09
-0.09 (-0.81%)
At close: Sep 15, 2025

Sinotherapeutics Company Description

Sinotherapeutics Inc., a specialty pharmaceutical company, develops generic and formulation products in China.

It offers posaconazole delayed-release tablets, ursodeoxycholic acid capsules, bupropion hydrochloride extended-release tablets, paroxetine extended-release tablets, sevelamer carbonate tablets, and propafenone hydrochloride extended-release capsules.

The company provides CRO/CDMO services including pre-formulation study, formulation and process development, clinical sample manufacturing, NDA registration batch manufacturing, quality standard establishment, and regulatory dossier document preparation and submission.

Sinotherapeutics Inc. was founded in 2012 and is headquartered in Shanghai, China.

Sinotherapeutics Inc.
CountryChina
Founded2012
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees312

Contact Details

Address:
Greenland Being Fun Plaza
Shanghai, 201210
China
Phone86 21 6881 9009
Websitesinotph.com

Stock Details

Ticker Symbol688247
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100005PL9
SIC Code2834

Key Executives

NamePosition
Yun Fang LarryDeputy General Manager
Kun LiDeputy General Manager
Fei ZhangAccounting Supervisor